Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) With Different Food Choices in the Outpatient Setting
NCT03767790 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2019-08-08
Summary
The objective of this randomized crossover clinical trial is to 1) assess the efficacy and safety of an automated insulin delivery (AID) system using a Model Predictive Control (MPC) algorithm versus sensor augmented pump therapy (SAP)/Predictive Low Glucose Suspend (PLGS) in people with type 1 diabetes, and 2) assess the impact of different meal macronutrient content on glucose control when using AID and SAP.
Conditions
- Type 1 Diabetes Mellitus
Interventions
- DEVICE
-
iAPS
The AID system (iAPS) is comprised of an insulin pump, a Dexcom G6 continuous glucose monitoring sensor, and a smart phone that contains the algorithm and communicates with the other devices.
Sponsors & Collaborators
- collaborator OTHER
-
Harvard School of Public Health (HSPH)
collaborator OTHER -
Sansum Diabetes Research Institute
lead OTHER
Principal Investigators
-
Eyal Dassau, PhD · John A. Paulson School of Engineering and Applied Sciences
-
David Eisenberg, MD · Harvard School of Public Health (HSPH)
-
Jordan E Pinsker, MD · Sansum Diabetes Research Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-03
- Primary Completion
- 2019-06-27
- Completion
- 2019-06-27
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Crossover Feasibility Study of Portable AP Device With Zone-MPC and HMS and Adapted I:C and Basal Insulin
NCT01929798 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Feasibility Evaluation of the APS APP
NCT03504046 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial
NCT03195140 ·Status: COMPLETED ·Phase: NA
-
Fault Detection, Zone MPC and DiAs System in T1D
NCT02773875 ·Status: UNKNOWN ·Phase: NA
-
A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes
NCT04667182 ·Status: WITHDRAWN
-
Exercise-Induced Hypoglycemia Prevention in Adults With Type 1 Diabetes Using an Artificial Pancreas
NCT03859401 ·Status: COMPLETED ·Phase: NA
-
A Multicenter Study of Outpatient Automated Blood Glucose Control With a Bihormonal Bionic Pancreas
NCT02092220 ·Status: COMPLETED ·Phase: NA
-
Automated Insulin Delivery in Pregnant Patients With Type 1 Diabetes With Extension Into Outpatient at Home
NCT04492566 ·Status: COMPLETED ·Phase: NA
-
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes
NCT02488616 ·Status: WITHDRAWN ·Phase: PHASE2
-
MPC Versus PID for Closed Loop Insulin Delivery
NCT02438670 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp
NCT01874392 ·Status: COMPLETED ·Phase: NA
-
Two Way Crossover Closed Loop Study R-AP vs MPC
NCT05083559 ·Status: COMPLETED ·Phase: NA
-
MMPPC Outpatient Clinical Protocol 2016
NCT02769884 ·Status: COMPLETED ·Phase: PHASE2
-
Two Way Crossover Closed Loop MPC vs Control IQ
NCT05799781 ·Status: COMPLETED ·Phase: NA
-
Outpatient Control-to-Range: System and Monitoring Testing
NCT01697150 ·Status: COMPLETED ·Phase: NA
-
An Outpatient Study of Automated Blood Glucose Control With an Insulin-Only Bionic Pancreas
NCT02536950 ·Status: COMPLETED ·Phase: NA
-
Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas
NCT01161862 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels
NCT04031599 ·Status: COMPLETED ·Phase: NA
-
Alleviating Carbohydrate-Counting Burden in T1DM Using Artificial Pancreas and Empagliflozin
NCT03510000 ·Status: COMPLETED ·Phase: NA
-
Android Artificial Pancreas System (Android APS) Versus Control-IQ
NCT05165615 ·Status: UNKNOWN ·Phase: NA
-
At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation
NCT02705053 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of Closed-Loop Glucose Control in People With Type 1 Diabetes (BPK004)
NCT00977808 ·Status: COMPLETED ·Phase: NA
-
Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas
NCT03262116 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
An Outpatient Pump Shutoff Pilot Feasibility and Safety Study
NCT01736930 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in China
NCT05726461 ·Status: UNKNOWN ·Phase: NA